A Waistline Predicted a Leaking Brain | The Angry Gut, Chapter 12

Leaky blood-brain barrier · waist size

Leaky Blood-Brain Barrier: The Body Numbers That Predict It Early

A leaky blood-brain barrier is predicted early by ordinary body numbers: among initially healthy older adults, a larger body mass index and a higher waist-to-hip ratio went with a leaking barrier two decades on, and in 1,015 people the leak followed diabetes rather than amyloid.

No office test can see the seal around your brain’s blood vessels. The forces that pry it open, though, show up in numbers most memory visits never collect.

Researchers can now watch contrast dye seep out of the smallest brain blood vessels in living people, and the first region to show it is the hippocampus, where new memories are filed. A leaky blood-brain barrier sounds like something only a research scanner could find. What predicts it is far more ordinary. Among older adults who were healthy at the start, heavier bodies and wider waists relative to hips foretold a leaking barrier twenty years on.

That thread runs through the video A Waistline Predicted a Leaking Brain, drawn from The Angry Gut by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes. Measura [Cardiometabolic and Autonomic Health Analysis] is a testing service. It measures; your physician interprets and treats. So the question here is narrow. If nobody can check the barrier at an ordinary appointment, which of the forces behind it can be put on paper?

What is a leaky blood-brain barrier?

The blood-brain barrier is the tightly sealed lining of the brain’s capillaries. It decides what passes from your bloodstream into brain tissue. Dr. Padda admits he once sketched it for trainees as a solid row of bricks, and living-patient imaging retired that sketch. With dynamic contrast MRI, older adults whose memory still tested normal showed permeability 41% higher in the hippocampus than young controls, and 107% higher in one of its subfields. In mild cognitive impairment, those regions rose further, by 24%, 53% and 27%, compared with age-matched peers.

The book gives this a precise vocabulary. The gut is the first brain. The organ in your skull is the second brain. The barrier is one of the borders between them, and what crosses it is best described as traffic: bacterial products and immune signals. A colony of bacteria living in a healthy brain has not been shown, and the most carefully controlled laboratory work argues against one.

Does a leaky blood-brain barrier show up before symptoms?

This is the finding that should change how you read a normal lab report. Among the volunteers with a leaking hippocampus, researchers also sampled spinal fluid, looking for familiar inflammatory messengers such as interleukin-6 and tumor necrosis factor. None had budged. Two things had: a marker of injury to pericytes, the cells that keep the barrier’s seams closed, which was up 115% in mild impairment, and the spinal fluid albumin ratio, up 30%.

A follow-up study of 161 people found no difference between impaired and unimpaired groups across 20 markers of inflammation and nerve degeneration, while the barrier measure still predicted who was impaired. The door opens first; inflammation shows up later. A clean inflammation panel does not prove the seal is intact.

What causes a leaky blood-brain barrier?

An older method compares albumin in spinal fluid with albumin in blood. Across 1,015 people, that ratio did not change in early Alzheimer’s disease and did not follow amyloid imaging or the APOE gene. It followed diabetes, and it rose alongside proteins that a strained blood-vessel lining sheds. A separate small study of type 2 diabetes found brain permeability already elevated before any vessel damage appeared on a conventional scan, and recent blood sugar control explained none of it.

Two biological drivers run through that record. One is years of high insulin and glucose load, the engine of metaflammation. The other is a vessel lining worn thin by that load. The third driver is not biological at all: a food supply engineered and subsidized to grow waistlines puts the problem in the pantry decades before it reaches a neurology office. The care system then splits the evidence. Your bowel belongs to one specialist, your memory to another, and your waist measurement to nobody.

What a routine memory visit records, and what it skips

A first visit for a memory complaint usually means a short screening test and a look at your medication list, sometimes followed by a brain scan. A borderline score often ends with advice to return in a year. What rarely gets written down are the numbers the barrier research keeps pointing toward: how much of your weight is fat, your fasting insulin, and whether either has drifted over a decade.

Be clear about the limit. Measura does not image the brain and does not measure barrier permeability. No office test does. That work belongs to research scanners and spinal fluid studies, and those two methods do not always agree with each other. What can be measured is the terrain those studies connect to the leak.

The measurements that close the gap

  • Bioimpedance body composition estimates how much of you is fat mass and how much is lean tissue. A bathroom scale and a body mass index chart cannot separate the two, and the barrier cohorts pointed at body shape, not weight alone.
  • Laboratory panels put numbers on the metabolic side, such as fasting insulin and blood sugar markers, so the insulin load is measured rather than assumed.
  • Arterial stiffness and endothelial function testing looks at how rigid your arteries are and how the vessel lining responds. It does not examine brain vessels, but the leak tracked vessel-lining strain, which makes your body’s own arteries a reasonable place to look.
  • Cognitive assessment gives memory, attention and processing speed a recorded baseline, so a borderline result becomes a starting line instead of a waiting period.

The brain-fuel side of memory is covered in what a normal blood sugar test can miss, and the reason a first score matters is laid out in what a cognitive baseline is for. Every result goes to your physician, who decides what it means for you. None of it is a reason to start or stop a medication on your own.

What to bring to your next appointment

The woman at the center of the video lived with bowel trouble for sixteen years before she ever raised a memory concern. Her sequence is worth copying as a habit.

  1. The year your bowel habits changed and the year your memory did. Years, not decades.
  2. Your waist measurement and weight history, and whether either moved in the last ten years.
  3. A request to check fasting insulin during the same visit as the memory complaint.
  4. A question about body composition, since two people at the same weight can carry very different amounts of fat.

The levers that move these numbers are food, meal timing, sleep and movement. No trial has yet shown that shrinking a waist narrows hippocampal leakage; the argument rests on mechanism and long cohorts, and acting on it does not have to wait. Every study with its limits is in the Chapter 12 Deep Dive. Clinicians can read the physician version of this screening question, and the next piece follows what fear does to digestion, measured.

Frequently asked questions

Can a blood test show a leaky blood-brain barrier?

No routine blood test can. Research teams use contrast MRI or compare albumin in spinal fluid and blood, and the two methods do not always agree. In people whose hippocampus was already leaking, common inflammatory markers had not moved. Blood work is more useful for the drivers linked to the leak, such as fasting insulin and blood sugar. See how insulin resistance is measured.

Is waist size linked to memory problems?

Among initially healthy older adults, a larger body mass index and a higher waist-to-hip ratio went with a leaking barrier two decades on, and in 1,015 people the leak followed diabetes rather than amyloid. That is an association, not proof that waist size causes memory loss. It does make body shape, and the fat behind it, worth measuring. Learn why body composition says more than BMI.

Can Measura test my blood-brain barrier?

No. Measura does not image the brain or measure barrier permeability, and no office-based test does. It measures the terrain research ties to the leak: body composition, metabolic blood work, arterial stiffness and vessel-lining function, plus a cognitive baseline. Results go to your physician, who decides whether anything needs further workup elsewhere. Read about memory and cognitive screening.

Are bacteria getting into the brain?

When one laboratory reran brain tissue with strict contamination controls, 54.8% of what looked like bacterial DNA had arrived with the lab reagents, and another 34.2% turned out to be human DNA that software had mislabeled. Molecules shed by bacteria, along with immune messengers, can still cross a weakened seal; what has not been shown is bacteria actually living there. See what any test result can and cannot tell you.

My memory score was borderline. Should I just wait a year?

A borderline score is a reason to record where you stand, not to stop asking. Barrier changes appeared in the hippocampus of people whose memory still tested normal, and the drivers linked to them, insulin load and body fat, can be measured now. Ask your physician whether a baseline and metabolic numbers make sense for you. Read which dementia risk numbers you can measure today.

What are the symptoms of a leaky blood-brain barrier?

Often there are none at first. In living-patient imaging, older adults whose memory still tested normal already showed hippocampal permeability 41% higher than young controls, and the leak rose further in mild cognitive impairment. Common inflammation markers had not moved, so a clean lab report does not prove the seal is intact. That is why the body numbers tied to the leak are worth recording before memory slips.

How do you fix a leaky blood-brain barrier?

No trial has yet shown that shrinking a waist narrows hippocampal leakage. The case rests on mechanism and long cohorts, and acting on it does not have to wait. The levers that move the linked numbers are food, meal timing, sleep and movement. Measuring body composition, fasting insulin and vessel-lining function gives you and your physician a baseline to see whether those numbers move.

Measure the terrain behind a memory complaint

Ask about Measura body composition, metabolic and cognitive testing, with results sent to the physician evaluating your memory.

4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

References

  • Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., Harrington, M. G., Chui, H. C., Law, M., & Zlokovic, B. V. (2015). Blood-brain barrier breakdown in the aging human hippocampus. Neuron, 85(2), 296-302. https://doi.org/10.1016/j.neuron.2014.12.032
  • Nation, D. A., Sweeney, M. D., Montagne, A., Sagare, A. P., D’Orazio, L. M., Pachicano, M., Sepehrband, F., Nelson, A. R., Buennagel, D. P., Harrington, M. G., Benzinger, T. L. S., Fagan, A. M., Ringman, J. M., Schneider, L. S., Morris, J. C., Chui, H. C., Law, M., Toga, A. W., & Zlokovic, B. V. (2019). Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nature Medicine, 25(2), 270-276. https://doi.org/10.1038/s41591-018-0297-y
  • Janelidze, S., Hertze, J., Nägga, K., Nilsson, K., Nilsson, C., Wennström, M., van Westen, D., Blennow, K., Zetterberg, H., & Hansson, O. (2017). Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype. Neurobiology of Aging, 51, 104-112. https://doi.org/10.1016/j.neurobiolaging.2016.11.017
  • Chen, Y. C., Lu, B. Z., Shu, Y. C., & Sun, Y. T. (2022). Spatiotemporal dynamics of cerebral vascular permeability in type 2 diabetes-related cerebral microangiopathy. Frontiers in Endocrinology, 12, 805637. https://doi.org/10.3389/fendo.2021.805637
  • Bedarf, J. R., Beraza, N., Khazneh, H., Ozkurt, E., Baker, D., Borger, V., Wullner, U., & Hildebrand, F. (2021). Much ado about nothing? Off-target amplification can lead to false-positive bacterial brain microbiome detection in healthy and Parkinson’s disease individuals. Microbiome, 9(1), 75. https://doi.org/10.1186/s40168-021-01012-1

Related reading

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, medical director of Measura. Last reviewed .

Filed under: